Pliant Therapeutics PLRX
NASDAQ PLRX
$1.08 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) EV to CFO (2020)

Updated

Pliant Therapeutics' (PLRX) EV to CFO came in at 31.91 for Q3 2020, up 531.4% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) EV to CFO (2020) Analysis & Trends

For the trailing twelve months through Sep 30, 2020, EV to CFO at Pliant Therapeutics was 50.34.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Pliant Therapeutics 66.87 Mn 66.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 31.91
Jun 30, 2020 5.05
API Access

Pliant Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PLRX&period=max&api_key=YOUR_API_KEY